Extendicare Inc

TSX:EXE

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXE's stock price target?

Price Target

8.16 CAD

According to Wall Street analysts, the average 1-year price target for EXE is 8.16 CAD with a low forecast of 7.58 CAD and a high forecast of 8.93 CAD.

What is Extendicare Inc's Revenue forecast?

Projected CAGR

1%

For the last 8 years the compound annual growth rate for Extendicare Inc's revenue is 4%. The projected CAGR for the next 3 years is 1%.

What is Extendicare Inc's Operating Income forecast?

Projected CAGR

-43%

For the last 8 years the compound annual growth rate for Extendicare Inc's operating income is 1%. The projected CAGR for the next 5 years is -43%.

What is Extendicare Inc's Net Income forecast?

Projected CAGR

5%

For the last 8 years the compound annual growth rate for Extendicare Inc's net income is -21%. The projected CAGR for the next 2 years is 5%.